PWM
BMY icon

Perigon Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Perigon Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.37M Sell
72,004
-666
-0.9% -$38.8K 0.08% 235
2025
Q4 		$3.92M Buy
72,670
+13,485
+23% +$649K 0.07% 247
2025
Q3 		$2.67M Buy
59,185
+5,655
+11% +$264K 0.05% 294
2025
Q2 		$2.48M Sell
53,530
-8,768
-14% -$430K 0.06% 294
2025
Q1 		$3.8M Buy
62,298
+2,205
+4% +$129K 0.1% 207
2024
Q4 		$3.39M Buy
60,093
+11,536
+24% +$645K 0.08% 221
2024
Q3 		$2.51M Buy
48,557
+8,169
+20% +$383K 0.07% 256
2024
Q2 		$1.68M Sell
40,388
-1,751
-4% -$78.3K 0.05% 277
2024
Q1 		$2.29M Sell
42,139
-5,720
-12% -$291K 0.07% 236
2023
Q4 		$2.46M Buy
47,859
+2,321
+5% +$122K 0.08% 205
2023
Q3 		$2.64M Sell
45,538
-10,299
-18% -$631K 0.11% 173
2023
Q2 		$3.57M Buy
55,837
+29,337
+111% +$1.97M 0.14% 146
2023
Q1 		$1.84M Sell
26,500
-530
-2% -$37.4K 0.1% 190
2022
Q4 		$1.94M Buy
27,030
+9,343
+53% +$704K 0.12% 173
2022
Q3 		$1.26M Sell
17,687
-141
-0.8% -$10.2K 0.11% 179
2022
Q2 		$1.37M Buy
17,828
+941
+6% +$71.7K 0.11% 170
2022
Q1 		$1.23M Buy
16,887
+5,956
+54% +$400K 0.09% 200
2021
Q4 		$682K Sell
10,931
-14,891
-58% -$874K 0.05% 280
2021
Q3 		$1.53M Sell
25,822
-4,922
-16% -$324K 0.13% 144
2021
Q2 		$2.05M Sell
30,744
-2,255
-7% -$147K 0.18% 105
2021
Q1 		$2.08M Buy
32,999
+1,670
+5% +$104K 0.21% 96
2020
Q4 		$1.94M Buy
31,329
+3,990
+15% +$245K 0.23% 82
2020
Q3 		$1.65M Sell
27,339
-3,274
-11% -$197K 0.23% 81
2020
Q2 		$1.8M Buy
30,613
+3,048
+11% +$182K 0.29% 68
2020
Q1 		$1.62M Sell
27,565
-1,328
-5% -$81.2K 0.3% 68
2019
Q4 		$1.82M Buy
28,893
+21,690
+301% +$1.24M 0.37% 55
2019
Q3 		$373K Sell
7,203
-2,055
-22% -$96.6K 0.09% 147
2019
Q2 		$420K Sell
9,258
-35
-0.4% -$1.63K 0.1% 138
2019
Q1 		$428K Sell
9,293
-400
-4% -$19.9K 0.1% 135
2018
Q4 		$478K Buy
9,693
+1,700
+21% +$91.3K 0.12% 126
2018
Q3 		$496K Sell
7,993
-475
-6% -$28.2K 0.12% 117
2018
Q2 		$469K Buy
8,468
+75
+0.9% +$4.05K 0.14% 129
2018
Q1 		$531K Buy
8,393
+1,520
+22% +$97.8K 0.2% 81
2017
Q4 		$421K Buy
6,873
+200
+3% +$12.5K 0.16% 80
2017
Q3 		$425K Sell
6,673
-5,780
-46% -$337K 0.14% 122
2017
Q2 		$694K Sell
12,453
-1,125
-8% -$61.2K 0.15% 146
2017
Q1 		$738K Buy
13,578
+185
+1% +$10.1K 0.16% 135
2016
Q4 		$767K Buy
13,393
+683
+5% +$37.3K 0.17% 130
2016
Q3 		$685K Sell
12,710
-487
-4% -$31.3K 0.18% 119
2016
Q2 		$971K Sell
13,197
-20
-0.2% -$1.41K 0.26% 102
2016
Q1 		$848K Hold
13,217
– – 0.26% 85
2015
Q4 		$910K Sell
13,217
-730
-5% -$48.2K 0.25% 105
2015
Q3 		$827K Hold
13,947
– – 0.25% 104
2015
Q2 		$928K Buy
13,947
+167
+1% +$11K 0.24% 100
2015
Q1 		$889K Sell
13,780
-250
-2% -$15.7K 0.24% 99
2014
Q4 		$828K Sell
14,030
-375
-3% -$21.1K 0.25% 96
2014
Q3 		$737K Sell
14,405
-935
-6% -$46.7K 0.22% 100
2014
Q2 		$744K Buy
15,340
+490
+3% +$24.1K 0.21% 102
2014
Q1 		$771K Buy
14,850
+1,050
+8% +$55.9K 0.42% 52
2013
Q4 		$733K Buy
+13,800
New +$703K 0.41% 50

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perigon Wealth Management's BMY Position: Q1 2026 in Review

Perigon Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 0.92% in Q1 2026, selling an estimated $38.8K and leaving 72,004 shares worth $4.37M. The position accounts for 0.08% of the portfolio, ranked #235.

Perigon Wealth Management first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Perigon Wealth Management held 72,004 shares of Bristol-Myers Squibb worth $4.37M as of Q1 2026.
  • Perigon Wealth Management sold 666 Bristol-Myers Squibb shares in Q1 2026, an estimated $38.8K.
  • Bristol-Myers Squibb made up 0.08% of Perigon Wealth Management's portfolio in Q1 2026, its #235 holding.
  • Perigon Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Perigon Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.